JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis
Authors:
- Hirofumi YamamotoHYHirofumi Yamamoto
- Ken—Ichi WakasaKWKen—Ichi Wakasa
- 1 August 2003
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 125 (2) , 556-571
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare (H12-Cancer-020)
- Cancer Research UK
This publication has 46 references indexed in Scilit:
- Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasmHepatology, 2001
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Choline Deficiency Causes Increased Localization of Transforming Growth Factor-β1 Signaling Proteins and Apoptosis in the Rat LiverPathobiology, 1997
- Proinflammatory Cytokines Regulate Cyclooxygenase-2 mRNA Expression in Human MacrophagesBiochemical and Biophysical Research Communications, 1995
- Increased Cell Proliferation of Azoxymethane‐induced Aberrant Crypt Foci of Rat ColonJapanese Journal of Cancer Research, 1994
- Prevention by acetylsailcylic acid of liver cirrhosis and carcinogenesis as well as generations of 8-hydroxydeoxyguanosine and thiobarbituric acid-reactive substances caused by a choline-deficient, L-amino acid-defined diet in ratsCarcinogenesis, 1994
- The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment StrategiesNew England Journal of Medicine, 1993
- Nonsteroidal Anti-inflammatory Drug Toxicity: Increased Risk in the ElderlyScandinavian Journal of Rheumatology, 1991
- Single GST-P positive liver cells — putative initiated. hepatocytesCarcinogenesis, 1987